Regulation of cholesterol metabolism by dietary plant sterols.
Renewal has occurred in the use of plant sterols for the treatment of hypercholesterolemias. A novel development was to convert plant sterols to corresponding stanols and esterify them to fat soluble form. In contrast to the crystalline plant sterols or stanols, plant stanol esters can be easily consumed during normal food intake in soluble form in different fat-containing food constituents when they have a potent cholesterol-lowering effect, shown in normo- and hypercholesterolemic men and women without or with coronary heart disease, children and diabetes. Cholesterol lowering is approximately 10% for total and 15% for LDL cholesterol, with the respective values for stanol ester margarine (2-3 g/day stanols) being 15% and 20%. Stanol esters reduce cholesterol absorption efficiency by up to 65%, increase cholesterol elimination in feces as cholesterol itself, usually not as bile acids, and stimulate cholesterol synthesis. Serum beta-carotene level is lowered, but no fat malabsorption or lowering of serum fat soluble vitamins have been observed. In contrast to plant sterols, stanols and their esters are minimally absorbed and they reduce serum plant sterol concentrations, also preventing statin-induced increase of plant sterols. Stanol ester margarine has been included in dietary treatment of hypercholesterolemia followed by the addition of drug treatment in resistant cases.
Miettinen
T A
TA
Department of Medicine, University of Helsinki, Finland.
Gylling
H
H
D002648:Child; D002784:Cholesterol / Q000097:blood / Q000145:classification / Q000378:metabolism*; D004952:Esters; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D007408:Intestinal Absorption / Q000187:drug effects; D008297:Male; D010944:Plants / Q000737:chemistry*; D016032:Randomized Controlled Trials as Topic; D013261:Sterols / Q000494:pharmacology* / Q000627:therapeutic use
D004952:Esters; D013261:Sterols; D002784:Cholesterol